[go: up one dir, main page]

NO20016221D0 - Difosfatsalt av et 4"-substituert-9-deokso-9A-aza-9A- homoerytromycinderivat og farmasöytisk preparat derav - Google Patents

Difosfatsalt av et 4"-substituert-9-deokso-9A-aza-9A- homoerytromycinderivat og farmasöytisk preparat derav

Info

Publication number
NO20016221D0
NO20016221D0 NO20016221A NO20016221A NO20016221D0 NO 20016221 D0 NO20016221 D0 NO 20016221D0 NO 20016221 A NO20016221 A NO 20016221A NO 20016221 A NO20016221 A NO 20016221A NO 20016221 D0 NO20016221 D0 NO 20016221D0
Authority
NO
Norway
Prior art keywords
deoxo
aza
substituted
pharmaceutical preparation
diphosphate salt
Prior art date
Application number
NO20016221A
Other languages
English (en)
Norwegian (no)
Other versions
NO20016221L (no
Inventor
Robert John Rafka
Colman Brendan Ragan
Douglas John Meldrum Allen
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20016221L publication Critical patent/NO20016221L/no
Publication of NO20016221D0 publication Critical patent/NO20016221D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO20016221A 1999-06-30 2001-12-19 Difosfatsalt av et 4"-substituert-9-deokso-9A-aza-9A- homoerytromycinderivat og farmasöytisk preparat derav NO20016221D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14168199P 1999-06-30 1999-06-30
PCT/IB2000/000785 WO2001002414A1 (en) 1999-06-30 2000-06-13 Diphosphate salt of a 4''-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition

Publications (2)

Publication Number Publication Date
NO20016221L NO20016221L (no) 2001-12-19
NO20016221D0 true NO20016221D0 (no) 2001-12-19

Family

ID=22496734

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20016221A NO20016221D0 (no) 1999-06-30 2001-12-19 Difosfatsalt av et 4"-substituert-9-deokso-9A-aza-9A- homoerytromycinderivat og farmasöytisk preparat derav

Country Status (42)

Country Link
US (3) US6465437B1 (es)
EP (1) EP1189913B1 (es)
JP (1) JP2003503506A (es)
KR (1) KR100442508B1 (es)
CN (2) CN101220067A (es)
AP (1) AP2001002370A0 (es)
AR (1) AR035551A1 (es)
AT (1) ATE286906T1 (es)
AU (1) AU772277B2 (es)
BG (1) BG65587B1 (es)
BR (1) BR0012091A (es)
CA (1) CA2376748C (es)
CO (1) CO5190679A1 (es)
CZ (1) CZ20014571A3 (es)
DE (1) DE60017399T2 (es)
EA (1) EA004235B1 (es)
EC (1) ECSP003555A (es)
EE (1) EE05068B1 (es)
ES (1) ES2233380T3 (es)
GT (2) GT200000105AA (es)
HN (1) HN2000000090A (es)
HR (1) HRP20010919B1 (es)
HU (1) HUP0201693A3 (es)
IL (1) IL146408A0 (es)
IS (1) IS6159A (es)
MA (1) MA26745A1 (es)
MX (1) MXPA02000058A (es)
MY (1) MY133360A (es)
NO (1) NO20016221D0 (es)
OA (1) OA11965A (es)
PA (1) PA8496901A1 (es)
PE (1) PE20010287A1 (es)
PL (1) PL201891B1 (es)
PT (1) PT1189913E (es)
SK (1) SK286243B6 (es)
TN (1) TNSN00143A1 (es)
TR (1) TR200103834T2 (es)
UA (1) UA71013C2 (es)
UY (1) UY26221A1 (es)
WO (1) WO2001002414A1 (es)
YU (1) YU88701A (es)
ZA (1) ZA200110453B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
US6791660B1 (en) * 2002-02-12 2004-09-14 Seiko Epson Corporation Method for manufacturing electrooptical device and apparatus for manufacturing the same, electrooptical device and electronic appliances
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
EP2736915A1 (en) 2011-07-27 2014-06-04 Farma GRS, d.o.o. New crystalline forms of tulathromycin
CN106008622A (zh) * 2016-08-02 2016-10-12 海门慧聚药业有限公司 泰拉霉素新晶型及其制备
CN110885351A (zh) * 2019-12-17 2020-03-17 海门慧聚药业有限公司 泰拉霉素磷酸盐的晶型及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43006B (en) * 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
SI9011409A (en) * 1990-07-18 1995-10-31 Pliva Pharm & Chem Works O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
JP2003512290A (ja) * 1997-09-10 2003-04-02 メルク エンド カムパニー インコーポレーテッド 家畜抗菌剤としての８ａ−アザライド
UA70972C2 (uk) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків
CA2372206C (en) * 1999-05-18 2006-01-10 Pfizer Products Inc. Novel crystalline forms of a macrolide antibiotic
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition

Also Published As

Publication number Publication date
BG106123A (en) 2002-05-31
EP1189913B1 (en) 2005-01-12
SK18922001A3 (sk) 2002-04-04
PA8496901A1 (es) 2002-08-26
HUP0201693A2 (en) 2002-10-28
NO20016221L (no) 2001-12-19
US20030092642A1 (en) 2003-05-15
MA26745A1 (fr) 2004-12-20
EA200101178A1 (ru) 2002-06-27
DE60017399T2 (de) 2006-03-30
DE60017399D1 (de) 2005-02-17
ES2233380T3 (es) 2005-06-16
MXPA02000058A (es) 2002-07-02
MY133360A (en) 2007-11-30
PE20010287A1 (es) 2001-03-05
EA004235B1 (ru) 2004-02-26
GT200000105A (es) 2001-12-20
CA2376748C (en) 2006-03-14
EE05068B1 (et) 2008-08-15
HUP0201693A3 (en) 2003-03-28
CN101220067A (zh) 2008-07-16
IL146408A0 (en) 2002-07-25
OA11965A (en) 2006-04-12
UY26221A1 (es) 2001-01-31
TNSN00143A1 (fr) 2005-11-10
UA71013C2 (uk) 2004-11-15
HRP20010919B1 (en) 2005-06-30
ZA200110453B (en) 2003-03-04
AR035551A1 (es) 2004-06-16
PL201891B1 (pl) 2009-05-29
SK286243B6 (sk) 2008-06-06
KR20020016875A (ko) 2002-03-06
IS6159A (is) 2001-11-13
JP2003503506A (ja) 2003-01-28
CZ20014571A3 (cs) 2002-04-17
US20040209826A1 (en) 2004-10-21
KR100442508B1 (ko) 2004-07-30
US7297682B2 (en) 2007-11-20
AU4943900A (en) 2001-01-22
CO5190679A1 (es) 2002-08-29
TR200103834T2 (tr) 2002-05-21
BG65587B1 (bg) 2009-01-30
BR0012091A (pt) 2002-04-02
PT1189913E (pt) 2005-04-29
YU88701A (sh) 2004-09-03
PL352900A1 (en) 2003-09-22
CA2376748A1 (en) 2001-01-11
HN2000000090A (es) 2001-04-20
ATE286906T1 (de) 2005-01-15
EE200100699A (et) 2003-02-17
AU772277B2 (en) 2004-04-22
US6861412B2 (en) 2005-03-01
US6465437B1 (en) 2002-10-15
AP2001002370A0 (en) 2001-12-31
ECSP003555A (es) 2002-01-25
CN1358188A (zh) 2002-07-10
GT200000105AA (es) 2001-12-20
EP1189913A1 (en) 2002-03-27
WO2001002414A1 (en) 2001-01-11
HRP20010919A2 (en) 2003-02-28

Similar Documents

Publication Publication Date Title
NO20000932L (no) Farmasøytisk preparat for kombinasjon av piperidinoalkanol og dekongestant
IS5245A (is) Lyfjablanda úr ómeprasól
NO20012248D0 (no) Farmasöytisk preparat av moksifloksacin
NO973938L (no) Farmasöytisk preparat av piperidinoalkanolforbindelser
NO2013004I2 (no) Axitinib, valgfritt i form av et farmasøytisk aksentabelt salt
NO973612D0 (no) Nytt farmasöytisk preparat
IS1981B (is) Nýtt form S-handhverfu ómeprasóls og lyfjablöndursem innihalda það
NO20042393L (no) Polymorf av et farmakum
NO970036D0 (no) Nytt oralt, farmasöytisk preparat inneholdende magnesiumsalt av omeprazol
NO20006576D0 (no) Et substituert triazol-pyridazinderivat og farmasöytiske preparater fremstilt av dette
NO180678C (no) N-substituerte heterocykliske forbindelser og farmasöytisk preparat
NO20016221D0 (no) Difosfatsalt av et 4"-substituert-9-deokso-9A-aza-9A- homoerytromycinderivat og farmasöytisk preparat derav
CY2007011I2 (el) Πολυμορφες ενος κρυσταλλικου κιτρικου αλατος αζαδικυκλο (2,2,2) οκταν -3- αμινης και φαρμακευτικες συνθεσεις τους
NO995039D0 (no) Gastrisk bibeholdt farmasöytisk preparat
FR2792318B1 (fr) Derives d'indazole, leur preparation et leur application en therapeutique
FI951155A0 (fi) Farmaseuttinen valmiste
NO20020777L (no) Farmasöytiske preparater inneholdende derivater og fremgangsmåte for fremstilling derav
NO20016030D0 (no) Derivater av 4'-demykarosyl-8a-aza-8a-homotylosin
DK1189913T3 (da) Diphosphatsalt af et 4"-substitueret-9-deoxo-9A-AZA-9A-homoerythromycin derivat og dettes farmaceutiske komposition
NO304427B1 (no) Piperidinester og medikament og farmas°ytisk preparat omfattende denne
IS6160A (is) Dífosfat salt af 4"-setinni-9-deoxó-9A-asa-9A-hómóerýtrómysín afleiðu og lyfjasamsetning þar af
FR2806723B1 (fr) DERIVES D'ACIDE 8-OXO-5,8-DIHYDRO-6H-DIBENZO [a,g] QUINOLIZINE-13-PROPANOIQUE , LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2797445B1 (fr) Derives d'ascididemine et leurs applications therapeutiques
NO20003284L (no) Farmasøytisk preparat for oral administrering

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application